Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors

Atherosclerosis

Volumn 207, Issue 1, 2009, Pages 181-185

  De Luca, Giuseppe ^a   Gibson, C Michael ^b   Bellandi, Francesco ^c   Noc, Marko ^d   Dudek, Dariusz ^e   Zeymer, Uwe ^f   Arntz, Hans Richard ^g   Cutlip, Donald ^h   Maioli, Mauro ^c   Zorman, Simona ^d   Mesquita Gabriel, H ⁱ   Emre, Ayse ^j   Rakowski, Tomasz ^e   Gyongyosi, Mariann ^k   Huber, Kurt ^l   van't Hof, Arnoud W J ^m  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Prato Hospital   (Italy)

^d UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^e JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^f KLINIKUM LUDWIGSHAFEN   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

ⁱ HOSPITAL DE SANTA MARIA   (Portugal)

^j DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^k MEDICAL UNIVERSITY OF VIENNA   (Austria)

^l Cardiology and Emergency Medicine   (Austria)

^m HOSPITAL DE WEEZENLANDEN   (Netherlands)

more..

Author keywords

Diabetes; Distal embolization; Myocardial perfusion; Primary angioplasty

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; TIROFIBAN;

ADULT; ANGIOCARDIOGRAPHY; ARTERY EMBOLISM; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; FEMALE; GENDER; HEART INFARCTION; HEART MUSCLE PERFUSION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; DIABETES COMPLICATIONS; ELECTROCARDIOGRAPHY; EMBOLISM; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 70449088656     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.03.042     Document Type: Article

References (38)

1. Antman E.M., Hand M., Armstrong P.W., et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 117 January (2) (2008) 296-329
2. Grines C.L., Browne K.F., Marco J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 328 (1993) 673-679
3. Zijlstra F., Hoorntje J.C.A., de Boer M.J., et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 341 (1999) 1413-1419
4. Suryapranata H., van't Hof A., Hoorntje J.C.A., de Boer M.J., and Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 97 (1998) 2502-2505
5. Stone G.W., Grines C.L., Cox D.A., et al. For the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Comparison of angioplasty with stenting with or without abciximab, in acute myocardial infarction. N Engl J Med 346 (2002) 957-966
6. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
7. Bolk J., van der Ploeg T., Cornel J.H., Arnold A.E., Sepers J., and Umans V.A. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 79 (2001) 207-214
8. Porter A., Assali A.R., Zahalka A., et al. Impaired fasting glucose and outcomes of ST-elevation acute coronary syndrome treated with primary percutaneous intervention among patients without previously known diabetes mellitus. Am Heart J 155 2 (2008 Feb) 284-289 [Epub 2007 Nov 26]
9. van't Hof A.W., Liem A., Suryapranata H., Hoorntje J.C., de Boer M.J., and Zijlstra F. On the behalf of the Zwolle Myocardial Infarction Study Group. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction. Myocardial Blush Grade. Circulation 97 (1998) 2302-2306
10. van't Hof A.W.J., Liem A., de Boer M.J., and Zijlstra F. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet 350 (1997) 615-619
11. Gibson C.M., Cannon C.P., Murphy S.A., et al. The relationship of the TIMI myocardial perfusion grade to mortality after thrombolytic administration. Circulation 101 (2000) 125-130
12. Marso S.P., Miller T., Rutherford B.D., et al. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial). Am J Cardiol 100 July (2) (2007) 206-210 [Epub 2007 Jun 4]
13. Ishihara M., Kagawa E., Inoue I., et al. Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era. Am J Cardiol 99 June (12) (2007) 1674-1679
14. Timmer J.R., van der Horst I.C., de Luca G., et al. Comparison of myocardial perfusion after successful primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction with versus without diabetes mellitus. Am J Cardiol 95 June (11) (2005) 1375-1377
15. Neumann F.J., Blasini R., Schmitt C., et al. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation 98 (1998) 2695-2701
16. De Luca G., Suryapranata H., Stone G.W., et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 293 (2005) 1759-1765
17. De Luca G., Gibson M., Bellandi F., et al. Early Glycoprotein IIb-IIIa inhibitors in Primary angioplasty (EGYPT) cooperation. An individual patients' data meta-analysis. Heart June (5) (2008) [Epub ahead of print]
18. Henriques J.P., Zijlstra F., Ottervanger J.P., et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 23 (2002) 1112-1117
19. Marfella R., Esposito K., Giunta R., et al. Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation 101 (2000) 2247-2251
20. Booth G., Stalker T.J., Lefer A.M., and Scalia R. Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. Am J Physiol Endocrinol Metab 280 (2001) E848-E856
21. Hokama J.Y., Ritter L.S., Davis-Gorman G., Cimetta A.D., Copeland J.G., and McDonagh P.F. Diabetes enhances leukocyte accumulation in the coronary microcirculation early in reperfusion following ischemia. J Diabetes Complications 14 (2000) 96-107
22. Engler R.L., Dahlgren M.D., Morris D.D., Peterson M.A., and Schmid-Schonbein G.W. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 251 (1986) H314-H323
23. Shechter M., Merz C.N., Paul-Labrador M.J., and Kaul S. Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease. J Am Coll Cardiol 35 (2000) 300-307
24. Sakuma T., Leong-Poi H., Fisher N.G., Goodman N.C., and Kaul S. Further insights into the no-reflow phenomenon after primary angioplasty in acute myocardial infarction: the role of microthromboemboli. J Am Soc Echocardiogr 16 (2003) 15-21
25. Nitenberg A., Valensi P., Sachs R., Dali M., Aptecar E., and Attali J.-R. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42 (1993) 1017-1025
26. Nahser Jr. P.J., Brown R.E., Oskarsson H., Winniford M.D., and Rossen J.D. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 91 (1995) 635-640
27. Ishihara M., Inoue I., Kawagoe T., Shimatani Y., et al. Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction. J Am Coll Cardiol 38 (2001) 1007-1011
28. Iwakura K., Ito H., Ikushima M., et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41 (2003) 1-7
29. Prasad A., Stone G.W., Stuckey T.D., et al. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol 45 (2005) 508-514
30. De Luca G., Suryapranata H., and Marino P. Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status. Prog Cardiovasc Dis 50 (2008) 352-382
31. De Luca G., Suryapranata H., Stone G.W., Antoniucci D., Neumann F.J., and Chiariello M. Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials. Am Heart J 153 (2007) 343-353
32. Vlaar P.J., Svilaas T., van der Horst I.C., et al. Cardiac death and reinfarction after 1 year in the thrombus aspiration during percutaneous coronary intervention in acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet 371 (2008) 1915-1920
33. De Luca G., Suryapranata H., Ottervanger J.P., and Antman E.M. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 109 (2004) 1223-1225
34. Gibson C.M., Kirtane A.J., Murphy S.A., et al. Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the time to integrilin therapy in acute myocardial infarction (TITAN)-TIMI 34 trial. Am Heart J 152 (2006) 668-675
35. Rakowski T., Zalewski J., Legutko J., et al. Early abciximab administration before primary percutaneous coronary intervention improves infarct-related artery patency and left ventricular function in high-risk patients with anterior wall myocardial infarction: a randomized study. Am Heart J 153 (2007) 360-365
36. Vogelzang M., Vlaar P.J., Svilaas T., Amo D., Nijsten M.W., and Zijlstra F. Computer-assisted myocardial blush quantification after percutaneous coronary angioplasty for acute myocardial infarction: a substudy from the TAPAS trial. Eur Heart J January (2009)
37. Korosoglou G., Haars A., Michael G., et al. Quantitative evaluation of myocardial blush to assess tissue level reperfusion in patients with acute ST-elevation myocardial infarction: incremental prognostic value compared with visual assessment. Am Heart J 153 (2007) 612-620
38. Marenzi G., Lauri G., Assanelli E., et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44 (2004) 1780-1785